Multifunctional neuroprotective-neurorescue drugs for Parkinson's disease

被引:3
|
作者
Van der Schyf, Cornelis J. [1 ]
Geldenhuys, Werner J. [1 ]
Youdim, Moussa B. H. [1 ]
机构
[1] Eve Topf & Natl Parkinson Fdn US, Fac Med, Ctr Excellence Neurodegenerat Dis, Efron St,POB 9697, IL-31096 Haifa, Israel
关键词
adenosine; dual mechanism; iron chelation; rasagiline;
D O I
10.2217/14796708.2.4.411
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Parkinson's disease (PD) is a severe neurodegenerative disorder, with no drugs currently approved to prevent the neuronal cell loss characteristic of brains of patients suffering from PD. Owing to the complex etiology of PD, an innovative approach towards neuroprotection or neurorescue may be the use of multifunctional pharmaceuticals that target an array of pathological pathways, each of which is believed to contribute to the cascade that ultimately leads to neuronal cell death. In this review, we discuss examples of novel multifunctional ligands that may have potential as neuroprotective-neurorescue therapeutics in PD. The compounds discussed originate from synthetic chemistry as well as from natural sources.
引用
收藏
页码:411 / 423
页数:13
相关论文
共 50 条
  • [1] Implications of co-morbidity for etiology and treatment of neurodegenerative diseases with multifunctional neuroprotective-neurorescue drugs; ladostigil
    Moussa B. H. Youdim
    Tamar Amit
    Orit Bar-Am
    Orly Weinreb
    Mara Yogev-Falach
    Neurotoxicity Research, 2006, 10 : 181 - 192
  • [2] Implications of co-morbidity for etiology and treatment of neurodegenerative diseases with multifunctional neuroprotective-neurorescue drugs; Ladostigil
    Youdim, Moussa B. H.
    Amit, Tamar
    Bar-Am, Orit
    Weinreb, Orly
    Yogev-Falach, Mara
    NEUROTOXICITY RESEARCH, 2006, 10 (3-4) : 181 - 192
  • [3] Why should we use multifunctional neuroprotective and neurorestorative drugs for Parkinson's disease?
    Youdim, Moussa B. H.
    Geldenhuys, Werner J.
    Van der Schyf, Cornelis J.
    PARKINSONISM & RELATED DISORDERS, 2007, 13 : S281 - S291
  • [4] Iron dysregulation in Alzheimer's disease: Multimodal brain permeable iron chelating drugs, possessing neuroprotective-neurorescue and amyloid precursor protein-processing regulatory activities as therapeutic agents
    Mandel, Silvia
    Amit, Tamar
    Bar-Am, Orit
    Youdim, Moussa B. H.
    PROGRESS IN NEUROBIOLOGY, 2007, 82 (06) : 348 - 360
  • [5] Parkinson's disease:: proteome and effect of neuroprotective drugs
    Mandel, S. A.
    Riederer, P.
    Gruenblatt, E.
    Youdim, M. B. H.
    AMINO ACIDS, 2007, 33 (03) : XXIV - XXIV
  • [6] Neuroprotective and neurorescue effect of black tea extract in 6-hydroxydopamine lesioned rat model of Parkinson's disease
    Chaturvedi, R. K.
    Shukla, S.
    Seth, K.
    Agrawal, A. K.
    JOURNAL OF NEUROCHEMISTRY, 2006, 98 : 8 - 8
  • [7] Why Do We Need Multifunctional Neuroprotective and Neurorestorative Drugs for Parkinson's and Alzheimer's Disorders?
    Youdim, Moussa B. H.
    RAMBAM MAIMONIDES MEDICAL JOURNAL, 2015, 6 (03):
  • [8] Why Do We Need Multifunctional Neuroprotective and Neurorestorative Drugs for Parkinson's and Alzheimer's Disorders?
    Moussa, B.
    Youdim, H.
    RAMBAM MAIMONIDES MEDICAL JOURNAL, 2010, 1 (02):
  • [9] Neurorescue Effect of EGCG in an Animal Model of Parkinson's Disease
    Xu, Qi
    Langley, Monica
    Kanthasamy, Anumantha
    Reddy, Manju
    FASEB JOURNAL, 2016, 30
  • [10] Neuroprotective and neurorescue effect of black tea extract in 6-hydroxydopamine-lesioned rat model of Parkinson's disease
    Chaturvedi, RK
    Shukla, S
    Seth, K
    Chauhan, S
    Sinha, C
    Shukla, Y
    Agrawal, AK
    NEUROBIOLOGY OF DISEASE, 2006, 22 (02) : 421 - 434